Understanding more about the effect of liposome nanoparticles on the immune system will improve drug delivery systems.
List view / Grid view
Quantum-Si's Next-Generation Protein Sequencing technology on Platinum™, rapidly distinguishes SARS-CoV-2 variants based on amino acid sequence.
A certain macrophage phenotype is more effective than another phenotype commonly used in cell therapy for infiltrating tumours.
Haematology research is a cradle of innovation, with many firsts in therapeutic approaches utilising the latest technology for the treatment of blood cancers. Anas Younes, Senior Vice President, Head of Haematology Oncology Research and Development at AstraZeneca, envisions a future where potential cures are within reach for more blood cancers…
Dr Rob van Montfort, a leading researcher at the Centre for Cancer Drug Discovery (CCDD) within The Institute of Cancer Research, London, is at the forefront of cancer drug discovery. Focusing on protein-ligand interactions, his work utilises structural biology and biochemical methods to help the discovery of novel small-molecule drugs…
Researchers have found that reducing glycosylation on the T cell surface may offer new approaches to cancer immunotherapy.
Listen to this podcast where we dive into genetic engineering, its role and relationship with allogeneic immunotherapy.
Extracellular vesicles loaded with mRNA encoding interferon-gamma offers promise for treating difficult tumours.
New open-source computational method called Spectra improves analysis of single-cell transcriptomic data.
Researchers have successfully demonstrated the potential of using a combination of inhibitors to effectively curb tumour growth and stave off relapses in patients afflicted with specific cancers.